1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow NA17-A antigen: new trials by email Literature Review of NA17-A antigen trials Research Report on NA17-A antigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Melanoma of the Eye MART-1 antigen, NA17-A antigen, gp100 antigen - Intraocular Melanoma | Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 13 | 2002-02-01 | 2012-09-24 |
Uveal Melanoma (1)
European Organisation for Research and Treatment of Cancer - EORTC (1)
Belgium (1) · Denmark (1)
Jan U. Prause, MD (1) · Vincent Brichard, MD (1)